MMPI < MPTP Poisoning < MSH Release-Inhibiting Hormone

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]

Ident.	Authors (with country if any)	Title
000754 (2002)	Dipankar Nandi [Royaume-Uni] ; Tipu Z. Aziz ; Xuguang Liu ; John F. Stein	Brainstem motor loops in the control of movement.
000755 (2002)	Hagai Bergman [Israël] ; Günther Deuschl	Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back.
001074 (2005)	Lance A. Smith [Royaume-Uni] ; Michael J. Jackson ; Ghassan Al-Barghouthy ; Sarah Rose ; Mikko Kuoppamaki ; Warren Olanow ; Peter Jenner	Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates.
001118 (2005)	Monty A. Silverdale [Royaume-Uni] ; S L Nicholson ; A R Crossman ; J M Brotchie	Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease.
001377 (2005)	Pierre-Olivier Fernagut [États-Unis] ; Imad Ghorayeb ; Elsa Diguet ; François Tison	In vivo models of multiple system atrophy.
001857 (2006)	Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft ; Steven G. Mcguire ; Jonathan M. Brotchie ; Alan R. Crossman ; Catherine Rochat ; Mark J. Millan	Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors.
002292 (2008)	Naomi P. Visanji [Canada] ; Rob M A. De Bie ; Tom H. Johnston ; Andrew C. Mccreary ; Jonathan M. Brotchie ; Susan H. Fox	The nociceptin/orphanin FQ (NOP) receptor antagonist J-113397 enhances the effects of levodopa in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
002720 (2009)	Glenda Halliday [Australie] ; Maria Trinidad Herrero ; Karen Murphy ; Heather Mccann ; Francisco Ros-Bernal ; Carlos Barcia ; Hideo Mori ; Francisco J. Blesa ; José A. Obeso	No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism.
002928 (2010)	Pershia Samadi [Canada] ; Marc Morissette ; Daniel Lévesque ; Thérèse Di Paolo	BDNF levels are not related with levodopa-induced dyskinesias in MPTP monkeys.
002989 (2010)	Kayhan A. Tayarani-Binazir [Royaume-Uni] ; Michael J. Jackson ; Sarah Rose ; C Warren Olanow ; Peter Jenner	Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets.
002B28 (2010)	Tom H. Johnston [Canada] ; Anne Van Der Meij ; Jonathan M. Brotchie ; Susan H. Fox	Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease.
002D81 (2010)	Louisa Clare Johnston [Royaume-Uni] ; Michael John Jackson ; Sarah Rose ; Andrew Christopher Mccreary ; Peter Jenner	Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP-treated common marmosets.
002F79 (2011)	Raymond T. Bartus [États-Unis] ; Christopher D. Herzog ; Yaping Chu ; Alistair Wilson ; Lamar Brown ; Joao Siffert ; Eugene M. Johnson ; C Warren Olanow ; Elliott J. Mufson ; Jeffrey H. Kordower	Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains.
003392 (2011)	Christopher Kobylecki [Royaume-Uni] ; Michael P. Hill ; Alan R. Crossman ; Paula Ravenscroft	Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease.
003794 (1990)	S. Boyce [Royaume-Uni] ; C E Clarke ; R. Luquin ; D. Peggs ; R G Robertson ; I J Mitchell ; M A Sambrook ; A R Crossman	Induction of chorea and dystonia in parkinsonian primates.
003798 (1990)	I J Mitchell [Royaume-Uni] ; R. Luquin ; S. Boyce ; C E Clarke ; R G Robertson ; M A Sambrook ; A R Crossman	Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia.
003926 (2013)	Jay S. Schneider [États-Unis] ; Elsa Y. Pioli ; Yang Jianzhong ; Qin Li ; Erwan Bezard	Levodopa improves motor deficits but can further disrupt cognition in a macaque Parkinson model.
003976 (2013)	Mariah J. Lelos ; Emma L. Lane ; Stephen B. Dunnett	What helps can also hinder: a dissociation in the acute effect of levodopa treatment on motor and cognitive functions.
003C31 (2013)	Maryka Quik ; Archana Mallela ; Jason Ly ; Danhui Zhang	Nicotine reduces established L-dopa-induced dyskinesias in a monkey model of Parkinson’s disease
003D38 (2013)	Giulia Costa [Italie] ; Lucia Frau ; Jadwiga Wardas ; Annalisa Pinna ; Antonio Plumitallo ; Micaela Morelli	MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice.
003F12 (2014)	Danhui Zhang [États-Unis] ; Tanuja Bordia [États-Unis] ; Matthew Mcgregor [États-Unis] ; J. Michael Mcintosh [États-Unis] ; Michael W. Decker [États-Unis] ; Maryka Quik [États-Unis]	ABT-089 and ABT-894 Reduce L-Dopa-Induced Dyskinesias in a Monkey Model of Parkinson’s Disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "MPTP Poisoning" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "MPTP Poisoning" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    MPTP Poisoning
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024